References
- 尹用甲. 東醫方劑와 處方解說. 서울:의성당. 2007:127-39.
- 全國韓醫科大學 共同敎材編纂委員會. 본초학. 서울:영림사. 2004:223-5, 334-5.
- 배병찬. 이묘산의 Adjuvant유발 류마티스 관절염 억제효과. 대구한의대학교 석사학위논문. 2011.
- 안희빈, 김순중, 서일복, 정수현. 二妙散이 흰쥐의 Monosodium Iodoacetate 유발 골관절염에 미치는 영향. 한방재활의학과학회지. 2010;20(3): 13-26.
- 이현우. 마우스 대식세포인 RAW 264.7에 대한 이묘산 메탄올 추출물의 항염증 효과. 동국대학교 박사학위논문. 2008.
- 서울대학교의과대학 내과학 교실. 최신지견 내과학. 서울:고려의학. 2005:128-35.
- 카톨릭의과대학 내과학 교실. Current Principles and Clinical Practice of Internal Medicine. 서울:군자출판사. 2005:466.
- Harrison, Tinsley Randolph, Kasper, Dennis L. Braunwald, Eugene.Fauci, Anthony S. Hauser, Stephen L. Longo, Dan L. Jameson, J.Larry. Harrison's principles of Internal Medicine. New York:Mc Graw Hill, 2006:1891-906.
- Oruc N, Ozutemiz AO, Yukselen V, Nart D, Ceilk HA, Yuce G, Batur Y. Infliximab : a new therapeutic agent in acute pancreatitis. Pancreas. 2004;28:D-e8.
- Fantini L, Tomassassetti P, Pezzilli R. Management of acute pancreatitis : current knowledge and future perspectives. World J Emerg Surg. 2006;1:16. https://doi.org/10.1186/1749-7922-1-16
- Lawinski M, Sledzinski Z, Kubasik-Juraniec J, Spodnik JH Wozniak M, Boguslawski W. Does resveratrol prevent free radical-induced acute pancreatitis. Pancreas. 2005;31:43-7. https://doi.org/10.1097/01.mpa.0000163021.40607.20
- 上海中醫學院. 中醫內科學. 上海:常務印書館香港分館. 1977:407-12.
- Arthur C. Guyton, John E hall. 의학 생리학. 서울:정담. 2002:857-61.
- Granger J, Remick D. Acute pancreatitis : models, markers, and mediators. Shock. 2005;24 Suppl 1:45-51. https://doi.org/10.1097/01.shk.0000191413.94461.b0
- Wagner AC, Mazzucchelli L, Miller M, Camoratto AM, Göke B. CEP-1347 inhibits caeruleininduced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2000;278(1):G165-72. https://doi.org/10.1152/ajpgi.2000.278.1.G165
- Frossard JL, Bhagat L, Lee HS, Hietaranta AJ, Singh VP, Song AM, Steer ML, Saluja AK. Both thermal and non-thermal stress protect against caerulein indeced pancreatitis and prevent trypsinogen activation in the pancreas. Gut. 2002;50(1):78-83. https://doi.org/10.1136/gut.50.1.78
- Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas. 1995;10(4):347-53. https://doi.org/10.1097/00006676-199505000-00005
- Norman J. The role of cytokines in the pathogensis of acute pancreatitis. An J Surg. 1998;175:76-83. https://doi.org/10.1016/S0002-9610(97)00240-7
- Galloway SW, Kingsnorth AN. Reduction in circulating levels of CD-4 positive lymphocytes in acute pancreatitis : relationship to endotoxin, interleukin 6 and disease severity. Br J Surg. 1994;81:312.
- Pessilli R, Billo P. Serum interleukin-6, interleukin-8 and beta 2 microglobulin in early assessment of severity of acute pancreatitis : comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341-8. https://doi.org/10.1007/BF02063235
- Inagaki T, Hoshino M, Hayakawa T, Ohara H, Yamada T, Yamada H, Iida M, Nakazawa T, Ogasawara T, Uchida A, Hasegawa C, Miyaji M, Takeuchi T. Interleukin 6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas. 1997;(1):1-8.
- YangYL, Li JP, Li KZ, Dou KF. Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis. World J Gastroenterol. 2004;10(19):2898-900. https://doi.org/10.3748/wjg.v10.i19.2898
- Grewal HP, Mohey EL, Din A, Gaber L, Kotb M, Gaber AO. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Wurg. 1994;167(1):214-8. https://doi.org/10.1016/0002-9610(94)90076-0
- Brivet FG, Emilie D, Galanaud P. Pro-and anti-inflammatory cytokines during acute severe pancreatitis : an early and sustainde response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med. 1999;27(4):749-55. https://doi.org/10.1097/00003246-199904000-00029
- Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2004;47(4):546-52.
- Norman JG, Fink GW, Denham W, Yang j, Carter G, Sexton C, Falkner J, Gower WR, Franz MG. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42(8):1783-8. https://doi.org/10.1023/A:1018886120711
- Hughes CB, Grewal HP, GAber LW, Kotb M, El-din AB, Mann L, Gaber AO. Anti-TNFalpha thearpy improves suvival and ameliorates the pathophysiologic wequelae in acute pancreatitis in the rat. Am J Surg. 1996;171(2):274-80. https://doi.org/10.1016/S0002-9610(97)89568-2
- Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in detemining out-come in murine lethal acute pancreatitis. Surgery. 1996;120(3):515-21. https://doi.org/10.1016/S0039-6060(96)80072-9
- Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995;108(6):1917-22. https://doi.org/10.1016/0016-5085(95)90158-2
- Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intranpancreatic tumor necrosis factor gene expression. Arch Surg. 1995;130(9):966-70. https://doi.org/10.1001/archsurg.1995.01430090052018
- Paahanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg. 1995;82(2):271-3. https://doi.org/10.1002/bjs.1800820244
- Scholmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol Suppl. 1996;219:37-42.
- Mozo G, del Olmo ML, Caro-Paton A, Reyes E, Manzano L, Belmonte A,Alvarez-Mon M. Lung changes and cytokine levels in a model of expermental acute pancreatitis. Rev Esp Enferm Dig. 2002;94(2):53-66.
- Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR Jr. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995;117(6):648-55. https://doi.org/10.1016/S0039-6060(95)80008-5
- Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 1995;221(6):625-31. https://doi.org/10.1097/00000658-199506000-00002
- Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, Mastsuura N, Mori T. Interleukin-1 receptor antagonist modifies the changes in vital organs induced bu acute necrotizing pancreatitis in a rat experimental model. Crit Care Med. 1995;23(5):901-8. https://doi.org/10.1097/00003246-199505000-00019
- Moshage H. Cytokine and the hepatic acute phase response. J Pathol. 1997;181:257-66. https://doi.org/10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U
- Pooran N, Indaram A, Singh P, Bank S. Cytokines(IL-6, IL-8,TNF) : early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol. 2003;37(3):236-6.
- Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in conparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas. 1991;6(3):253-9. https://doi.org/10.1097/00006676-199105000-00001